Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nyse  >  Mallinckrodt PLC    MNK   IE00BBGT3753

MALLINCKRODT PLC

(MNK)
  Report  
 SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Quotes 5-day view   Delayed Quote. Delayed Nyse
09/10/2019 09/11/2019 09/12/2019 09/13/2019 09/16/2019 Date
3.88(c) 3.36(c) 2.99(c) 3.3(c) 3.01(c) Last
53 332 812 36 356 462 10 801 875 17 253 832 9 281 766 Volume
+84.76% -13.40% -11.01% +10.37% -8.79% Change
More quotes
Financials (USD)
Sales 2019 3 189 M
EBIT 2019 1 127 M
Net income 2019 273 M
Debt 2019 5 104 M
Yield 2019 -
Sales 2020 3 063 M
EBIT 2020 1 034 M
Net income 2020 331 M
Debt 2020 4 438 M
Yield 2020 -
P/E ratio 2019 0,83x
P/E ratio 2020 0,69x
EV / Sales2019 1,68x
EV / Sales2020 1,53x
Capitalization 253 M
More Financials
Company
Mallinckrodt public limited company develops, manufactures, markets and distributes branded and generic specialty pharmaceutical products and therapies. The Company focuses on various therapeutic areas, such as autoimmune and rare disease specialty areas, including neurology, rheumatology,... 
Sector
Pharmaceuticals
Calendar
11/11Earnings Release
More about the company
Surperformance© ratings of Mallinckrodt PLC
Trading Rating : Investor Rating :
More Ratings
Latest news on MALLINCKRODT PLC
09/16MALLINCKRODT : Analysis Suggests Acthar Gel May be a Cost-Effective Option Compa..
AQ
09/13Correction to Opioid Reckoning Hits Money Managers
DJ
09/13Opioid Reckoning Hits Money Managers
DJ
09/13MALLINCKRODT : Analysis Suggests Acthar® Gel (Repository Corticotropin Injection..
PR
09/11NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/11NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/11NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/10NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/10NEWS HIGHLIGHTS : Top Company News of the Day
DJ
09/10NEWS HIGHLIGHTS : Top Company News of the Day
DJ
More news
Analyst Recommendations on MALLINCKRODT PLC
More recommendations
Sector news : Specialty & Advanced Pharmaceuticals
04:46pALEXION PHARMACEUTICALS : Names New Finance Chief
DJ
03:38pU.S. Senators urge FTC to scrutinize multi-billion dollar pharma mergers
RE
10:33aABBVIE : Form 8.3 - Allergan Plc
DJ
08:18aBAYER : Invests $20 Million in U.S.-Based Informed Data Systems
DJ
07:15aMerck Gets FDA Priority Review for Investigational Ebola Zaire Virus Vaccine
DJ
More sector news : Specialty & Advanced Pharmaceuticals
Chart MALLINCKRODT PLC
Duration : Period :
Mallinckrodt PLC Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MALLINCKRODT PLC
Short TermMid-TermLong Term
TrendsNeutralBearishBearish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 15
Average target price 5,52  $
Last Close Price 2,71  $
Spread / Highest target 564%
Spread / Average Target 104%
Spread / Lowest Target -63,1%
EPS Revisions
Managers
NameTitle
Mark C. Trudeau President, Chief Executive Officer & Director
Angus C. Russell Chairman
Frank Scholz EVP-Global Operations & Digital Innovation Officer
George A. Kegler Chief Financial Officer & Executive VP
Steven Romano Chief Scientific Officer & EVP
Sector and Competitors
1st jan.Capitalization (M$)
MALLINCKRODT PLC-80.95%253
MERCK KGAA AG10.58%47 575
WUXI APPTEC CO LTD51.43%18 573
KYOWA KIRIN CO LTD1.38%10 212
ZHANGZHOU PIENTZEHUANG PHARMACEUTICL LTD15.45%8 454
JAZZ PHARMACEUTICALS PLC8.11%7 588